OCLN and infection: Compared to RV-A1-infected placebo-treated cells, RV-A1-infected ECSN6-treated cells showed no increase in occludin at 24 h post-infection (Supplemental Fig. 3C), probably because RV-A1 did not disrupt intercellular junctions in ECSN6-treated cultures.